Vårdrelaterade infektioner med multiresistenta bakterier - Inte bara stafylokocker

Lakartidningen

Volumn 103, Issue 35, 2006, Pages 2478-2481

  Petersson, Johan ^a   Giske, Christian G ^a   Aufwerber, Ewa ^a   Jörbeck, Hans ^b  

^a Anestesi Och Intensivvårdskliniken ^*  (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; COLISTIN;

ACINETOBACTER INFECTION; ADULT; ARTICLE; BACTERIAL INFECTION; CASE REPORT; CROSS INFECTION; DISEASE TRANSMISSION; HUMAN; INFECTION CONTROL; MALE; MICROBIOLOGY; MULTIDRUG RESISTANCE; THAILAND; TRAVEL; WOUND INFECTION;

ACINETOBACTER INFECTIONS; ADULT; ANTI-BACTERIAL AGENTS; COLISTIN; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INFECTION CONTROL; MALE; THAILAND; TRAVEL; WOUND INFECTION;

EID: 33748661715     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Canton R, Coque TM, Baquero F. Multi-resistant Gram-negative bacilli: from epidemics to endemics. Curr Opin Infect Dis. 2003;16(4):315-25.
2. Clark NM, Patterson J, Lynch JP 3rd. Antimicrobial resistance among gram-negative organisms in the intensive care unit. Curr Opin Crit Care. 2003;9(5):413-23.
3. Livermore DM. The need for new antibiotics. Clin Microbiol Infect. 2004;10(Suppl 4):1-9.
4. Coelho J, Woodford N, Turton J, Livermore DM. Multiresistant acinetobacter in the UK: how big a threat? J Hosp Infect. 2004;58(3): 167-9.
5. Schulte B, Goerke C, Weyrich P, Grobner S, Bahrs C, Wolz C, et al. Clonal spread of meropenem-resistant Acinetobacter baumannii strains in hospitals in the Mediterranean region and transmission to South-west Germany. J Hosp Infect. 2005;61(4):356-7.
6. Bergogne-Berezin E. The increasing role of Acinetobacter species as nosocomial pathogens. Curr Infect Dis Rep. 2001;3(5):440-4.
7. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996;9(2):148-65.
8. Abbo A, Navon-Venezia S, Hammer-Muntz O, Krichali T, Siegman-Igra Y, Carmeli Y. Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis. 2005;11(1):22-9.
9. Corbella X, Montero A, Pujol M, Dominguez MA, Ayats J, Argerich MJ, et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol. 2000;38(11):4086-95.
10. Waterer GW, Wunderink RG. Increasing threat of Gram-negative bacteria. Crit Care Med. 2001;29(4 Suppl):N75-81.
11. Manikal VM, Landman D, Saurina G, Oydna E, Lal H, Quale J. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis. 2000; 31(1):101-6.
12. Fluit AC, Verhoef J, Schmitz FJ. Frequency of isolation and antimicrobial resistance of gram-negative and gram-positive bacteria from patients in intensive care units of 25 European university hospitals participating in the European arm of the SENTRY Antimicrobial Surveillance Program 1997-1998. Eur J Clin Microbiol Infect Dis. 2001;20 (9):617-25.
13. Spencer RC. Predominant pathogens found in the European Prevalence of Infection in Intensive Care Study. Eur J Clin Microbiol Infect Dis. 1996;15(4):281-5.
14. Garnacho-Montero J, Ortiz-Leyba C, Fernandez-Hinojosa E, Aldabo-Pallas T, Cayuela A, Marquez-Vacaro JA, et al. Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intensive Care Med. 2005;31(5):649-55.
15. Hanberger H, Diekema D, Fluit A, Jones R, Struelens M, Spencer R, et al. Surveillance of antibiotic resistance in European ICUs. J Hosp Infect. 2001;48(3):161-76.
16. Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005;40(9): 1333-41.
17. Garnacho-Montero J, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar AE, Garcia-Garmendia JL, Bernabeu-Wittel IM, et al. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis. 2003;36(9): 1111-8.
18. Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents. 2005;25: 11-25.
19. Reina R, Estenssoro E, Sáenz G, Canales HS, Gonzalvo R, Vidal G, et al. Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study. Intensive Care Med. 2005;31(5): 1058-65.
20. Referensgruppen för antibiotikafrågor (RAF), Strategigruppen för rationell antibiotikaanvändning och minskad antibiotikaresistens (STRAMA) och Svensk förening för Vårdhygien (SFVH). Multiresistenta bakterier - ett svenskt vårdprogram, 2005. http://www.srga.org/MRB/index.html, november 2005.